Patrick M Sweeney & Associates Inc. Sells 31,111 Shares of CVS Health Co. (NYSE:CVS)

Patrick M Sweeney & Associates Inc. decreased its position in CVS Health Co. (NYSE:CVS - Free Report) by 46.6% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 35,610 shares of the pharmacy operator's stock after selling 31,111 shares during the period. CVS Health makes up 1.8% of Patrick M Sweeney & Associates Inc.'s portfolio, making the stock its 17th largest position. Patrick M Sweeney & Associates Inc.'s holdings in CVS Health were worth $1,599,000 at the end of the most recent quarter.

A number of other large investors have also made changes to their positions in CVS. State Street Corp increased its holdings in shares of CVS Health by 3.6% in the third quarter. State Street Corp now owns 56,527,909 shares of the pharmacy operator's stock worth $3,554,475,000 after acquiring an additional 1,989,066 shares in the last quarter. Geode Capital Management LLC increased its stake in CVS Health by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 26,361,673 shares of the pharmacy operator's stock worth $1,651,997,000 after purchasing an additional 461,569 shares in the last quarter. Pzena Investment Management LLC raised its holdings in CVS Health by 1.5% during the 3rd quarter. Pzena Investment Management LLC now owns 13,135,308 shares of the pharmacy operator's stock worth $825,948,000 after buying an additional 198,920 shares during the period. Charles Schwab Investment Management Inc. boosted its holdings in shares of CVS Health by 2.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 12,208,668 shares of the pharmacy operator's stock valued at $767,681,000 after buying an additional 304,386 shares during the period. Finally, Hotchkis & Wiley Capital Management LLC increased its position in shares of CVS Health by 34.8% during the third quarter. Hotchkis & Wiley Capital Management LLC now owns 11,897,034 shares of the pharmacy operator's stock worth $748,085,000 after acquiring an additional 3,071,613 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on CVS shares. Wells Fargo & Company raised shares of CVS Health from an "equal weight" rating to an "overweight" rating and upped their target price for the stock from $60.00 to $66.00 in a research note on Monday, November 18th. UBS Group upped their price objective on CVS Health from $60.00 to $62.00 and gave the stock a "neutral" rating in a research report on Thursday, November 7th. Deutsche Bank Aktiengesellschaft raised CVS Health from a "hold" rating to a "buy" rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. Barclays reduced their price target on CVS Health from $75.00 to $71.00 and set an "overweight" rating for the company in a research report on Thursday, November 7th. Finally, Mizuho cut their price objective on shares of CVS Health from $73.00 to $66.00 and set an "outperform" rating on the stock in a research report on Thursday, October 24th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $68.12.

CVS Health Stock Performance

Shares of CVS stock traded up $1.25 on Tuesday, reaching $57.45. The stock had a trading volume of 14,018,429 shares, compared to its average volume of 13,772,261. CVS Health Co. has a 12 month low of $43.56 and a 12 month high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The firm has a market capitalization of $72.29 billion, a price-to-earnings ratio of 14.58, a P/E/G ratio of 0.80 and a beta of 0.59. The firm's 50-day moving average is $51.24 and its two-hundred day moving average is $56.19.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The business's revenue was up 6.3% on a year-over-year basis. During the same period last year, the firm posted $2.21 earnings per share. On average, research analysts expect that CVS Health Co. will post 5.22 EPS for the current fiscal year.

CVS Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Shareholders of record on Thursday, January 23rd will be issued a $0.665 dividend. The ex-dividend date of this dividend is Thursday, January 23rd. This represents a $2.66 annualized dividend and a dividend yield of 4.63%. CVS Health's dividend payout ratio is currently 67.51%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.